U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07891104) titled 'A Phase I/II Clinical Trial of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine Adsorbed' on Oct. 10.
Brief Summary: This is a randomized, positive-controlled phase I/II clinical trial to evaluate the safety and preliminary immunogenicity of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine Adsorbed in subjects aged 2 Months to 6 Years.
Study Start Date: Oct. 11
Study Type: INTERVENTIONAL
Condition:
Diphtheria
Pertussis
Tetanus
Poliomyelitis
Diphtheria-Tetanus-aPertussis-Poliomyelitis Vaccines
Intervention:
BIOLOGICAL: Diphtheria...